![Chemical structure of 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, CAS 501-36-0](https://api.angenesci.com/structure/1648/501-36-0.png)
No data
No data
No data
| CAS Number | 501-36-0 |
| Catalog Number | AG0035KE(AGN-PC-0OB77W) |
| Chemical Name | 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol |
| IUPAC Name | 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol |
| InChI | InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ |
| InChI Key | LUKBXSAWLPMMSZ-OWOJBTEDSA-N |
| MDL Number | MFCD00133799 |
| Molecular Formula | C14H12O3 |
| Molecular Weight | 228.2433 |
| NSC Number | 327430 |
| SMILES | OC1=CC=C(/C=C/C=2C=C(C=C(C2)O)O)C=C1 |
| UNII | Q369O8926L |
| Synonyms | 3,4',5-stilbenetriol,
3,4',5-Trihydroxystilbene,
3,5,4'-trihydroxystilbene,
cis Resveratrol,
cis-resveratrol,
resveratrol,
Resveratrol 3 sulfate,
Resveratrol, (Z)-,
resveratrol-3-sulfate,
SRT 501,
SRT-501,
SRT501,
trans Resveratrol,
trans Resveratrol 3 O sulfate,
trans-resveratrol,
trans-resveratrol-3-O-sulfate,
resveratrol,
501-36-0,
trans-resveratrol,
3,4',5-Trihydroxystilbene,
3,5,4'-Trihydroxystilbene,
(E)-5-(4-Hydroxystyryl)benzene-1,3-diol,
(E)-resveratrol,
3,4',5-Stilbenetriol,
Resvida,
3,4',5-Trihydroxy-trans-stilbene,
5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol,
SRT-501,
SRT501,
3,5,4'-Trihydroxy-trans-stilbene,
Resveratol,
5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol,
5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol,
3,4',5-trihydroxy-stilbene,
Resveratrol, natural,
UNII-Q369O8926L,
CHEBI:45713,
trans-3,4',5-trihydroxystilbene,
(E)-5-(p-Hydroxystyryl)resorcinol,
trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene,
5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol,
CHEMBL165,
NSC 327430,
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol,
MLS000069735,
1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-,
LUKBXSAWLPMMSZ-OWOJBTEDSA-N,
C14H12O3,
trans-3,4',5 - trihydroxystilbene,
MFCD00133799,
NSC327430,
Q369O8926L,
5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol,
trans-3,4′,5-Trihydroxystilbene,
1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-,
SMR000058206,
DSSTox_CID_11980,
DSSTox_RID_78898,
DSSTox_GSID_31980,
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol,
(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol,
SRT 501,
STL,
SR-01000000163,
5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol,
CHEBI:27881,
CCRIS 8952,
HSDB 7571,
3fts,
4jaz,
4qer,
Resveratrol, E-,
Resveratrol,(S),
KUC104385N,
Stilbene, 2f,
TaxusChinensisiRehd,
NCGC00015894-02,
PREVENTION 8 (RESVERATROL),
AK-39118,
CAS-501-36-0,
Prestwick_619,
Resveratrol, trans-,
Resveratrol, 99%,
KSC-10-164,
Resveratrol, synthetic,
RM-1812,
Opera_ID_586,
AC1L9HIC,
Prestwick2_000508,
Prestwick3_000508,
Spectrum5_000552,
R 5010,
Lopac0_001111,
REGID_for_CID_6240,
SCHEMBL19425,
BSPBio_000435,
BSPBio_001114,
BSPBio_003461,
MLS001055357,
MLS001076538,
MLS001424228,
MLS002207121,
MLS002222231,
ARONIS24568,
SPECTRUM1502223,
CU-01000001503-3,
BPBio1_000479,
cid_445154,
GTPL8741,
SGCUT00007,
trans-Stilbene-3,4',5-triol,
ZINC6787,
Resveratrol, analytical standard,
DTXSID4031980,
REGID_for_CID_445154,
BDBM23926,
Resveratrol, >=99% (HPLC),
BBC/741,
BIK9013,
2l98,
BCPP000091,
HMS1362H15,
HMS1569F17,
HMS1792H15,
HMS1921N04,
HMS1990H15,
HMS2052I09,
HMS2096F17,
HMS2232A18,
HMS3263O04,
HMS3403H15,
HMS3649A20,
HMS3676O14,
ACT09778,
BCP01416,
to_000079,
ZX-AS004941,
ZX-AT013797,
Tox21_110257,
Tox21_201374,
Tox21_303376,
Tox21_501111,
ABP000376,
AC-727,
AN-865,
BBL028252,
BS0159,
CCG-38874,
CR-003,
GP2549,
GP5884,
LMPK13090005,
s1396,
SBB055452,
STL146386,
AKOS005720936,
Tox21_110257_1,
ACN-034773,
API0000480,
CS-1050,
DB02709,
KS-5047,
LP01111,
LS-2146,
MCULE-5678456463,
NC00349,
NSC-327430,
OR46018,
RP17549,
SB17273,
SDCCGMLS-0002998.P003,
IDI1_002152,
Resveratrol solution, 100 mM in DMSO,
NCGC00017352-05,
NCGC00017352-06,
NCGC00017352-07,
NCGC00017352-08,
NCGC00017352-09,
NCGC00017352-10,
NCGC00017352-11,
NCGC00017352-12,
NCGC00017352-13,
NCGC00017352-14,
NCGC00017352-15,
NCGC00017352-16,
NCGC00017352-17,
NCGC00017352-18,
NCGC00017352-19,
NCGC00017352-24,
NCGC00024003-00,
NCGC00024003-04,
NCGC00024003-05,
NCGC00024003-06,
NCGC00024003-07,
NCGC00024003-08,
NCGC00024003-09,
NCGC00024003-10,
NCGC00024003-11,
NCGC00024003-12,
NCGC00024003-13,
NCGC00024003-14,
NCGC00257465-01,
NCGC00258925-01,
NCGC00261796-01,
4CN-0696,
AJ-08292,
AS-12413,
BC202036,
BR-39118,
CC-34242,
CJ-00111,
CPD000058206,
HY-16561,
SAM001246888,
SC-11924,
ST057251,
ZB000650,
AB0006623,
AX8004672,
ST2408097,
TL8003323,
EU-0101111,
FT-0082623,
N1848,
R0071,
Resveratrol, Vetec(TM) reagent grade, 98%,
SW196786-4,
01R360,
A10785,
C03582,
J10118,
N88795,
5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol,
AB00052942-29,
AB00052942_31,
A827984,
5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol,
I06-0437,
SR-01000000163-3,
SR-01000000163-4,
SR-01000000163-9,
5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol,
5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol,
5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol,
5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol,
BRD-K25591257-001-01-2,
BRD-K80738081-001-06-2,
BRD-K80738081-001-07-0,
BRD-K80738081-001-09-6,
BRD-K80738081-001-10-4,
BRD-K80738081-001-23-7,
SR-01000000163-10,
SR-01000000163-11,
SR-01000000163-16,
(E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene,
(E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene,
5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol,
Resveratrol, certified reference material, TraceCERT(R),
1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-,
Resveratrol, European Pharmacopoeia (EP) Reference Standard,
533C1DA0-4104-42B5-9D32-9265F40857E4,
trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard,
3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol,
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol,
InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1,
trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol,
cis-resveratrol,
Tocilizumab,
Cis resveratrol,
trans Resveratrol,
(Z)-resveratrol,
trans -Resveratrol,
Resveratrol, (Z)-,
resveratrol-3-sulfate,
Trans-3,4&prime,
,5-Trihydroxystilbene,
Resveratrol 3 sulfate,
UNII-AUA0K06FSB,
D0U3EP,
Resveratrol (Z)-form [MI],
trans-resveratrol-3-O-sulfate,
trans Resveratrol 3 O sulfate,
CID445154,
ACN-040108,
C14-H12-O3,
CS-O-02277,
Resveratrol, 98% - 500MG 500mg,
A4182,
S-2390,
C059514,
5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol,
D000077185,
1,3-Benzenediol, 5-((1Z)-2-(4-hydroxyphenyl)ethenyl)-,
1,3-Benzenediol, 5-((E)-2-(4-hydroxyphenyl)ethenyl)-,
61434-67-1,
375823-41-9,
RV,
|
| Complexity | 246 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Exact Mass | 228.079g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 17 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 228.247g/mol |
| Monoisotopic Mass | 228.079g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 60.7A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.1 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H319 |
| Packing Group | |
| Precautionary statements | P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

